title: Blood disorders stepping into the limelight.
authors.affiliation: Department of Hematology, Medical University of Vienna, Austria.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jäger
authors.affiliation: Hôpital Saint Louis, Institut Universitaire d'Hématologie, Paris, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Chomienne
authors.affiliation: Center for Human Genetics, KU Leuven, Belgium Center for the Biology of Disease, VIB, Leuven, Belgium.
authors.forename: Jan
authors.initials: J
authors.lastname: Cools
authors.affiliation: European Hematology Association, The Hague, The Netherlands c.smand@ehaweb.org.
authors.forename: Carin
authors.initials: C
authors.lastname: Smand
mesh_terms: D006402:Hematologic Diseases / Q000175:diagnosis / Q000191:economics / Q000473:pathology / Q000628:therapy*; D006405:Hematology / Q000191:economics / Q000379:methods*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000191:economics / Q000639:trends*
references.citation: N Engl J Med. 2000 Dec 28;343(26):1910-6
references.pmid: 11136261
references.citation: N Engl J Med. 2010 Aug 12;363(7):640-52
references.pmid: 20818855
references.citation: Int J Cancer. 2015 Feb 15;136(4):E136-45
references.pmid: 25066804
references.citation: Haematologica. 2016 Feb;101(2):115-208
references.pmid: 26819058